New Research Progress of a New Auxiliary Antihypertensive Model Targeting Intestinal Flora

doi:10.12114/j.issn.1007-9572.2022.02.023

Abstract

Abstract:

As an important part of the internal environment of human, intestinal flora participates in and regulates the immune inflammatory response and metabolic process of the body. It is closely related to the occurrence and development of hypertension, and has become the focus of research on hypertension. The thesis summarizes the relationship between intestinal flora and hypertension, then clarifies their effects and possible mechanisms on hypertension in terms of inflammation and immune response, brain-intestine-bone marrow axis and metabolites, focusing on the new auxiliary antihypertensive pathways that dietary intervention affects intestinal flora to improve blood pressure from salt, probiotics and polyphenols. It is hoped that more in-depth research will come out on improving hypertension through dietary intervention and Chinese herbal medicine prevention and treatment with intestinal flora as the target.

Key words: Hypertension, Gastrointestinal microbiome, Intestinal flora, Microbial control, Dietary intervention

摘要：

肠道菌群是人体内环境的重要组成部分，参与和调节机体的免疫炎性反应和代谢过程，与高血压的发生、发展存在密切联系，在高血压疾病的研究中已成为焦点。本文总结了肠道菌群与高血压的关系，从炎症和免疫反应、脑-肠-骨髓轴、代谢物等方面阐明肠道菌群对高血压的影响及可能机制，重点从盐、益生菌、多酚类有机化合物三方面探讨饮食干预影响肠道菌群、改善血压的新型辅助降压途径，以期以肠道菌群为靶点，使通过饮食、中草药防治高血压的研究越来越深入。

关键词: 高血压, 胃肠道微生物组, 肠道菌群, 微生物控制, 饮食干预

Xiaojun HUANG,Jin YANG,Yaqimei LEI, et al. New Research Progress of a New Auxiliary Antihypertensive Model Targeting Intestinal Flora[J]. Chinese General Practice, 2022, 25(18): 2297-2302. DOI: 10.12114/j.issn.1007-9572.2022.02.023.
黄筱钧,杨锦,雷亚琪美等. 以肠道菌群为靶点的新型辅助降压模式研究进展[J]. 中国全科医学, 2022, 25(18): 2297-2302. DOI: 10.12114/j.issn.1007-9572.2022.02.023.

References 60

[1]	胡盛寿，高润霖，刘力生，等. 《中国心血管病报告2018》概要[J]. 中国循环杂志，2019，34(3):209-220. DOI：10.3969/j.issn.1000-3614.2019.03.001.
[2]	杨若言，吴利利，吴阿莉，等. 肠道菌群与肥胖关系的研究进展[J]. 中国微生态学杂志，2019，31(8):969-975,993. DOI：10.13381/j.cnki.cjm.201908024.
[3]	中国高血压防治指南修订委员会，高血压联盟（中国），中华医学会心血管病学分会，等.中国高血压防治指南（2018年修订版）[J]. 中国心血管杂志，2019，24(1):24-56. DOI：10.3969/j.issn.1007-5410.2019.01.002.
[4]	朱玮，范荆阳，薛庆节，等. 人体肠道菌群与高血压的研究进展[J]. 中国微生态学杂志，2021，33(9):1109-1112. DOI：10.13381/j.cnki.cjm.202109025.
[5]	周丹，黄雨晴，余雪菊，等. 肠道菌群与心血管病关系的研究进展[J]. 中华高血压杂志，2018，26(5):417-423. DOI：10.16439/j.cnki.1673-7245.2018.05.005.
[6]	VAN HECKE T, DE VRIEZE J, BOON N，et al. Combined consumption of beef-based cooked mince and sucrose stimulates oxidative stress，cardiac hypertrophy，and colonic outgrowth of Desulfovibrionaceae in rats[J]. Mol Nutr Food Res，2019，63(2):e1800962. DOI：10.1002/mnfr.201800962.
[7]	LI J, ZHAO F Q, WANG Y D，et al. Gut microbiota dysbiosis contributes to the development of hypertension[J]. Microbiome，2017，5(1):14. DOI：10.1186/s40168-016-0222-x.
[8]	YANG T, SANTISTEBAN M M, RODRIGUEZ V，et al. Gut dysbiosis is linked to hypertension[J]. Hypertension，2015，65(6):1331-1340. DOI：10.1161/HYPERTENSIONAHA.115.05315.
[9]	WALEJKO J M, KIM S, GOEL R，et al. Gut microbiota and serum metabolite differences in African Americans and White Americans with high blood pressure[J]. Int J Cardiol，2018，271:336-339. DOI：10.1016/j.ijcard.2018.04.074.
[10]	张维忠. 高血压治疗研究的回顾与展望[J]. 中华心血管病杂志，2000，28 (3):167. DOI：10.3760/j:issn:0253-3758.2000.03.002.
[11]	ZHERNAKOVA A, KURILSHIKOV A, BONDER M J，et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity[J]. Science，2016，352(6285):565-569. DOI：10.1126/science.aad3369.
[12]	MADHUR M S, LOB H E, MCCANN L A，et al. Interleukin 17 promotes angiotensinⅡ-induced hypertension and vascular dysfunction[J]. Hypertension，2010，55(2):500-507. DOI：10.1161/HYPERTENSIONAHA.109.145094.
[13]	KNAUF F, BREWER J R, FLAVELL R A. Immunity，microbiota and kidney disease[J]. Nat Rev Nephrol，2019，15(5):263-274. DOI：10.1038/s41581-019-0118-7.
[14]	喻静，彭红英. 肠道菌群介导的免疫反应与高血压和慢性肾脏病的关系研究进展[J]. 解放军医学杂志，2021，46(9):865-870. DOI：10.11855/j.issn.0577-7402.2021.09.04.
[15]	BARTOLOMAEUS H, BALOGH A, YAKOUB M，et al. Short-chain fatty acid propionate protects from hypertensive cardiovascular damage[J]. Circulation，2019，139(11):1407-1421. DOI：10.1161/CIRCULATIONAHA.118.036652.
[16]	XING J L, WANG G, ZHANG Q X，et al. Determining antioxidant activities of lactobacilli cell-free supernatants by cellular antioxidant assay：a comparison with traditional methods[J]. PLoS One，2015，10(3):e0119058. DOI：10.1371/journal.pone.0119058.
[17]	AGUS A, DENIZOT J, THÉVENOT J，et al. Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive E.coli infection and intestinal inflammation[J]. Sci Rep，2016，6:19032. DOI：10.1038/srep19032.
[18]	吴箴言，刘美君，谭林琳，等. 氧化三甲胺与心血管疾病研究进展[J]. 中国实验诊断学，2020，24(11):1916-1919. DOI：10.3969/j.issn.1007-4287.2020.11.048.
[19]	SHEN X Z, LI Y, LI L，et al. Microglia participate in neurogenic regulation of hypertension[J]. Hypertension，2015，66(2):309-316. DOI：10.1161/HYPERTENSIONAHA.115.05333.
[20]	YANG T, RICHARDS E M, PEPINE C J，et al. The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease[J]. Nat Rev Nephrol，2018，14(7):442-456. DOI：10.1038/s41581-018-0018-2.
[21]	BROWN J M, HAZEN S L. Microbial modulation of cardiovascular disease[J]. Nat Rev Microbiol，2018，16(3):171-181. DOI：10.1038/nrmicro.2017.149.
[22]	NATARAJAN N, HORI D, FLAVAHAN S，et al. Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41[J]. Physiol Genomics，2016，48(11):826-834. DOI：10.1152/physiolgenomics.00089.2016.
[23]	HSU C N, HOU C Y, CHAN J Y H，et al. Hypertension programmed by perinatal high-fat diet：effect of maternal gut microbiota-targeted therapy[J]. Nutrients，2019，11(12):E2908. DOI：10.3390/nu11122908.
[24]	ZUBCEVIC J, RICHARDS E M, YANG T，et al. Impaired autonomic nervous system-microbiome circuit in hypertension[J]. Circ Res，2019，125(1):104-116. DOI：10.1161/CIRCRESAHA.119.313965.
[25]	陈彦豪，赵先英. 内源性硫化氢与心血管疾病的研究进展[J]. 河北医药，2018，40(15):2365-2367. DOI：10.3969/j.issn.1002-7386.2018.15.034.
[26]	阮亮亮，李金蓉. 血液中氧化三甲胺与相关疾病及检测方法[J]. 生命的化学，2021，41(2):339-343. DOI：10.13488/j.smhx.20200471.
[27]	JIANG S, SHUI Y J, CUI Y，et al. Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II-induced hypertension[J]. Redox Biol，2021，46:102115. DOI：10.1016/j.redox.2021.102115.
[28]	赵君，杜金行，汪国梁，等. 中药治疗原发性高血压随机对照试验的Meta分析[J]. 中华中医药杂志，2018，33(3):922-926.
[29]	赵鑫，付志飞，高秀梅. 基于肠道益生菌的中药防治疾病作用研究进展[J]. 世界科学技术-中医药现代化，2019，21(6):1097-1102. DOI：10.11842/wst.2019.06.009.
[30]	DEY P. Gut microbiota in phytopharmacology：a comprehensive overview of concepts，reciprocal interactions，biotransformations and mode of actions[J]. Pharmacol Res，2019，147:104367. DOI：10.1016/j.phrs.2019.104367.
[31]	葛均波，徐永健. 内科学[M]. 8版. 北京：人民卫生出版社，2013.
[32]	VAN BEUSECUM J P, BARBARO N R, MCDOWELL Z，et al. High salt activates CD11c⁺ antigen-presenting cells via SGK （serum glucocorticoid kinase） 1 to promote renal inflammation and salt-sensitive hypertension[J]. Hypertension，2019，74(3):555-563. DOI：10.1161/HYPERTENSIONAHA.119.12761.
[33]	WILCK N, MATUS M G, KEARNEY S M，et al. Salt-responsive gut commensal modulates TH17 axis and disease[J]. Nature，2017，551(7682):585-589. DOI：10.1038/nature24628.
[34]	MATTHIAS J, HEINK S, PICARD F，et al. Salt generates antiinflammatory Th17 cells but amplifies pathogenicity in proinflammatory cytokine microenvironments[J]. J Clin Invest，2020，130(9):4587-4600. DOI：10.1172/JCI137786.
[35]	FERGUSON J F, ADEN L A, BARBARO N R，et al. High dietary salt-induced dendritic cell activation underlies microbial dysbiosis-associated hypertension[J]. JCI Insight，2019，5:126241. DOI：10.1172/jci.insight.126241.
[36]	ELIJOVICH F, KLEYMAN T R, LAFFER C L，et al. Immune mechanisms of dietary salt-induced hypertension and kidney disease：harry goldblatt award for early career investigators 2020[J]. Hypertension，2021，78(2):252-260. DOI：10.1161/HYPERTENSIONAHA.121.16495.
[37]	YAN X F, JIN J J, SU X H，et al. Intestinal flora modulates blood pressure by regulating the synthesis of intestinal-derived corticosterone in high salt-induced hypertension[J]. Circ Res，2020，126(7):839-853. DOI：10.1161/CIRCRESAHA.119.316394.
[38]	LEWIS-MIKHAEL A M, DAVOODVANDI A, JAFARNEJAD S. Effect of Lactobacillus plantarum containing probiotics on blood pressure：a systematic review and meta-analysis[J]. Pharmacol Res，2020，153:104663. DOI：10.1016/j.phrs.2020.104663.
[39]	HENDIJANI F, AKBARI V. Probiotic supplementation for management of cardiovascular risk factors in adults with type Ⅱdiabetes：a systematic review and meta-analysis[J]. Clin Nutr，2018，37(2):532-541. DOI：10.1016/j.clnu.2017.02.015.
[40]	GÓMEZ-GUZMÁN M, TORAL M, ROMERO M，et al. Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats[J]. Mol Nutr Food Res，2015，59(11):2326-2336. DOI：10.1002/mnfr.201500290.
[41]	GRYLLS A, SEIDLER K, NEIL J. Link between microbiota and hypertension：focus on LPS/TLR4 pathway in endothelial dysfunction and vascular inflammation，and therapeutic implication of probiotics[J]. Biomedecine Pharmacother，2021，137:111334. DOI：10.1016/j.biopha.2021.111334.
[42]	TORAL M, ROMERO M, RODRÍGUEZ-NOGALES A，et al. Lactobacillus fermentum improves tacrolimus-induced hypertension by restoring vascular redox state and improving ENOS coupling[J]. Mol Nutr Food Res，2018，62(14):e1800033. DOI：10.1002/mnfr.201800033.
[43]	UPADRASTA A, MADEMPUDI R S. Probiotics and blood pressure：current insights[J]. Integr Blood Press Control，2016，9:33-42. DOI：10.2147/IBPC.S73246.
[44]	LUCA S V, MACOVEI I, BUJOR A，et al. Bioactivity of dietary polyphenols：the role of metabolites[J]. Crit Rev Food Sci Nutr，2020，60(4):626-659. DOI：10.1080/10408398.2018.1546669.
[45]	SINGH A P, SINGH R, VERMA S S，et al. Health benefits of resveratrol：evidence from clinical studies[J]. Med Res Rev，2019，39(5):1851-1891. DOI：10.1002/med.21565.
[46]	马晓聪，熊兴江，莫毅，等. 基于16S rDNA测序技术的自发性高血压大鼠肠道菌群结构变化及中药干预作用[J]. 中华中医药学刊，2020，38(8):71-74,后插7-后插8. DOI：10.13193/j.issn.1673-7717.2020.08.017.
[47]	韩聪，姜月华，李伟，等. 基于16S rDNA测序技术探索黄芪-丹参药对干预自发性高血压大鼠肠道菌群的机制[J]. 中华中医药杂志，2019，34(5):2233-2237.
[48]	CHEN M L, YI L, ZHANG Y，et al. Resveratrol attenuates trimethylamine-N-oxide （TMAO）-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota[J]. mBio，2016，7(2):e02210-02215. DOI：10.1128/mBio.02210-15.
[49]	KIM T T, PARAJULI N, SUNG M M，et al. Fecal transplant from resveratrol-fed donors improves glycaemia and cardiovascular features of the metabolic syndrome in mice[J]. Am J Physiol Endocrinol Metab，2018，315(4):E511-519. DOI：10.1152/ajpendo.00471.2017.
[50]	WANG C, HUANG Z X, YU K Q，et al. High-salt diet has a certain impact on protein digestion and gut microbiota：a sequencing and proteome combined study[J]. Front Microbiol，2017，8:1838. DOI：10.3389/fmicb.2017.01838.
[51]	SONG H N, LEE S Y. High concentration of sodium chloride could induce the viable and culturable states of Escherichia coli O157：H7 and Salmonella enterica serovar Enteritidis[J]. Lett Appl Microbiol，2021，72(6):741-749. DOI：10.1111/lam.13468.
[52]	黄庆发. 高盐饮食改变肠道菌群结构导致高血压的发生[D]. 广州：南方医科大学，2020.
[53]	VAN OOSTROM A J, SIJMONSMA T P, RABELINK T J，et al. Postprandial leukocyte increase in healthy subjects[J]. Metabolism，2003，52(2):199-202. DOI：10.1053/meta.2003.50037.
[54]	ROWLAND I, GIBSON G, HEINKEN A，et al. Gut microbiota functions：metabolism of nutrients and other food components[J]. Eur J Nutr，2018，57(1):1-24. DOI：10.1007/s00394-017-1445-8.
[55]	GOMES A, OUDOT C, MACIÀ A，et al. Berry-enriched diet in salt-sensitive hypertensive rats：metabolic fate of （poly）phenols and the role of gut microbiota[J]. Nutrients，2019，11(11):E2634. DOI：10.3390/nu11112634.
[56]	DALIRI E B, LEE B H, OH D H. Current perspectives on antihypertensive probiotics[J]. Probiotics Antimicrob Proteins，2017，9(2):91-101. DOI：10.1007/s12602-016-9241-y.
[57]	常化松，袁雯雯，玄红专，等. 黄酮类化合物吸收代谢及其对胃肠道功能影响的研究进展[J]. 食品工业科技，2019，40(18):340-347. DOI：10.13386/j.issn1002-0306.2019.18.054.
[58]	TE RIET L, VAN ESCH J H M, ROKS A J M，et al. Hypertension：renin-angiotensin-aldosterone system alterations[J]. Circ Res，2015，116(6):960-975. DOI：10.1161/CIRCRESAHA.116.303587.
[59]	HSU C N, HOU C Y, CHAN J Y H，et al. Hypertension programmed by perinatal high-fat diet：effect of maternal gut microbiota-targeted therapy[J]. Nutrients，2019，11(12):E2908. DOI：10.3390/nu11122908.
[60]	JANG I A, KIM E N, LIM J H，et al. Effects of resveratrol on the renin-angiotensin system in the aging kidney[J]. Nutrients，2018，10(11):E1741. DOI：10.3390/nu10111741.